Visibility:     Module:   
Search   Register   Login
Search Pink Ribbon News

with all of the words
without the words
Search Results
1999/12/01 The San Antonio Breast Cancer Symposium: Past to Present
The 22nd annual San Antonio Breast Cancer Symposium was held December 8-11, 1999, at the San Antonio Marriott Rivercenter. The Symposium-attended by approximately 3,000 medical oncologists, surgeons, radiation oncologists, basic scientists, affiliated health care professionals, and breast cancer adv

1999/10/29 FDA Approves Tamoxifen
Komen Foundation Supports FDA Decision POSTED OCT. 29, 1999 DALLAS - The Susan G. Komen Breast Cancer Foundation supports the Food and Drug Administration's (FDA) approval of Nolvadex (tamoxifen citrate) for reducing the incidence of breast cancer in women at high risk for developing the disease.

1999/10/02 Reaching for the Cure: The Next Step
 Reaching for the Cure: The Next Step October 2-3, 1999 Westin Park Central Hotel Dallas, Texas The annual grant conference of the Susan G. Komen Breast Cancer Foundation provides an opportunity for recipients of national grants, members of Komen Affiliates, and others involved in breast ca

1999/08/01Tamoxifen New Study Examines Resistance
Tamoxifen is a drug taken in pill form that interferes with the activity of estrogen and has been used to treat both early and advanced stage breast cancer for more than 20 years. The drug belongs to a class of drugs called SERMs, Selective Estrogen Receptor Modulators, which have both anti-estrogen

1999/04/15 Early Results of Stem Cell Transplant Studies Released
DALLAS - April 15, 1999 - Preliminary abstracts of five studies on the use of high-dose chemotherapy with autologous bone marrow or stem cell transplant (HDC/BMT) for breast cancer patients were released today by the American Society of Clinical Oncology (ASCO). Data in four of the five abstracts sh

1 Found:5


Copyright 1997-2011 Pink Ribbon Inc. / Pink Ribbon International   Terms and Conditions  Privacy Policy